Option Care Health, Inc. $OPCH Shares Bought by Seizert Capital Partners LLC

Seizert Capital Partners LLC increased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 118.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 127,523 shares of the company’s stock after acquiring an additional 69,055 shares during the period. Seizert Capital Partners LLC’s holdings in Option Care Health were worth $3,540,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Live Oak Investment Partners bought a new stake in Option Care Health in the third quarter worth about $913,000. Massachusetts Financial Services Co. MA grew its stake in shares of Option Care Health by 2.7% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,244,321 shares of the company’s stock worth $34,542,000 after purchasing an additional 33,019 shares during the last quarter. MeadowBrook Investment Advisors LLC bought a new stake in shares of Option Care Health in the 3rd quarter worth approximately $105,000. TD Private Client Wealth LLC raised its holdings in shares of Option Care Health by 32.4% in the 3rd quarter. TD Private Client Wealth LLC now owns 10,592 shares of the company’s stock worth $294,000 after purchasing an additional 2,592 shares in the last quarter. Finally, Nordea Investment Management AB lifted its stake in Option Care Health by 1.9% during the third quarter. Nordea Investment Management AB now owns 97,070 shares of the company’s stock valued at $2,674,000 after purchasing an additional 1,780 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were acquired at an average cost of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Cowen initiated coverage on shares of Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating on the stock. Bank of America boosted their target price on Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Jefferies Financial Group reaffirmed a “buy” rating and set a $37.00 target price on shares of Option Care Health in a report on Tuesday, January 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research report on Monday, December 29th. Finally, Citigroup restated an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and an average price target of $37.50.

Option Care Health Price Performance

Shares of OPCH opened at $36.04 on Tuesday. The business’s 50-day moving average is $31.66 and its 200-day moving average is $29.54. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05. The company has a market capitalization of $5.72 billion, a price-to-earnings ratio of 28.57, a P/E/G ratio of 2.15 and a beta of 0.80. Option Care Health, Inc. has a fifty-two week low of $24.24 and a fifty-two week high of $36.32.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.